Botulinum Toxin Relieves Anxiety, Depression and Sleep Disorderes in Patients With Blepharospasm
Clinical trial NCT04939909 · UNKNOWN
Trial details
- NCT number
- NCT04939909
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-12
- Primary completion
- 2021-12-24
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.